FDA: errors with drug labels

The US Food and Drug Administration (FDA) have issued their monthly overview of drug label errors. The following drugs required modifications to be made due to errors: Aplenzin (Bupropion Hydrobromide) Atrovent HFA (Ipratropium Bromide HFA) Avelox (Moxifloxacin Hydrochloride) Bactrim (Sulfamethoxazole and Trimethoprim) Capoten (Captopril) Coartem (Artemether/Lumefantrine) Complera (Emtricitabine, Rilpivirine, Tenofovir Diovan (Valsartan)Bactrim DS (Sulfamethoxazole and Trimethoprim) Diovan HCT (Valsartan/Hydrochlorothiazide) Disoproxil Fumarate) Edurant (Rilpivirine) Fuzeon (Enfuvirtide) Intelence (Etravirine) Invega Sustenna (Paliperidone Palmitrate) Isentress (Raltegravir) Lamictal (Lamotrigine) and Lamictal XR (Lamotrigine) Leustatin (Cladribine) Lovaza (Omega-3-Acid Ethyl Esters) Lucentis (Ranibizumab) Mirapex (Pramipexole Dihydrochloride) and Mirapex ER (Pramipexole Dihydrochloride) Moviprep (PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate and Ascorbic Acid) Neoral Soft Gelatin (Cyclosporine) Neoral oral Solution (Cyclosporine) Nexavar (Sorafenib) Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) Ortho Evra (Norelgestromin/Ethinyl Estradiol) Oxaliplatin (Oxaliplatin) Revatio (Sildenafil) Sanctura XR (Trospium Chloride) Sandimmune (Cyclosporine, USP) Selzentry (Maraviroc) Strattera (Atomoxetine Hydrochloride) Sustiva (Efavirenz) Toviaz (Fesoterodine Fumarate) Tradjenta (Linagliptin) Trobicin (Spectinomycin) Ultane and Ultane NovaPlus (Sevoflurane) Vectibix (Panitumumab) Viread (Tenofovir Disoproxil Fumarate For more details, see FDA Medwatch.